Ftse Mib
34.465,68
-0,40%
DAX
18.680,20
-0,25%
S&P 500
5.320,55
-0,02%
NASDAQ
16.819,57
-0,08%
Bitcoin
70.143,69
0,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alpha Tau Medical Ltd (DRTSW) Alpha Tau Medical Ltd (DRTSW) Notizie

DRTSW

Alpha Tau Medical (DRTSW)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTSW
DataOraFonteTitoloSimboloCompagnia
21/05/202414:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
21/05/202414:45GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
20/05/202422:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
13/05/202414:30GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
06/05/202414:30GlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSWAlpha Tau Medical Ltd
01/05/202414:30GlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
25/03/202413:50GlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSWAlpha Tau Medical Ltd
07/03/202422:01GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
26/02/202414:30GlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
20/12/202315:15GlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
29/11/202314:30GlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
28/11/202314:30GlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
20/11/202314:30GlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
16/11/202322:30GlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
30/10/202313:30GlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSWAlpha Tau Medical Ltd
24/10/202315:00GlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSWAlpha Tau Medical Ltd
14/09/202314:30GlobeNewswire Inc.Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterNASDAQ:DRTSWAlpha Tau Medical Ltd
28/08/202322:02GlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
17/08/202323:00GlobeNewswire Inc.Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTNASDAQ:DRTSWAlpha Tau Medical Ltd
24/05/202322:01GlobeNewswire Inc.Alpha Tau Medical to Participate in June Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
23/05/202322:01GlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
17/05/202322:30GlobeNewswire Inc.Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityNASDAQ:DRTSWAlpha Tau Medical Ltd
11/05/202322:00GlobeNewswire Inc.Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenNASDAQ:DRTSWAlpha Tau Medical Ltd
03/05/202322:00GlobeNewswire Inc.Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayNASDAQ:DRTSWAlpha Tau Medical Ltd
03/04/202315:10GlobeNewswire Inc.Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical TrialNASDAQ:DRTSWAlpha Tau Medical Ltd
29/03/202322:00GlobeNewswire Inc.Alpha Tau Medical to Present at Jefferies Radiopharma Innovation SummitNASDAQ:DRTSWAlpha Tau Medical Ltd
12/03/202313:30GlobeNewswire Inc.Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley BankNASDAQ:DRTSWAlpha Tau Medical Ltd
09/03/202322:10GlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
08/03/202323:00GlobeNewswire Inc.Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialNASDAQ:DRTSWAlpha Tau Medical Ltd
03/03/202314:30GlobeNewswire Inc.Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem HeadquartersNASDAQ:DRTSWAlpha Tau Medical Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DRTSW

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network